Frontiers in Pediatrics · 2019 · 21 citations · 30 references
MedicineDevelopmental BiologyPediatricsNeonatologyPreterm BirthStem Cell BiologyBronchopulmonary DysplasiaCare Of Premature InfantsNeonatal DevelopmentNeonatal OutcomesCord Blood CellsGestational Age MeasurementNeonatal Hematopoietic Stem Cell BiologyRespiratory Outcomes In PrematurityUmbilical Cord Blood Stem CellsUmbilical Cord-derived CellsUmbilical Cord-derived Mesenchymal Stem Cells
Objective. To test the hypothesis that umbilical cord blood-derived CD34+ hematopoietic stem cells (HPSC), cord tissue-derived CD90+ and CD105+ mesenchymal stem cells (MSC) vary with bronchopulmonary dysplasia (BPD). Methods. We conducted a prospective longitudinal study at a large birth center (Prentice Women’s Hospital in Chicago, IL). Premature infants (N=200) were enrolled in 2:1:1 ratio based on gestational age (GA): mildly preterm (31-32 weeks), moderately preterm (29-30w) and extremely preterm (23-28w). Cord blood (CB) and cord tissues (CT) were collected at birth using commercial banking kits, and analyzed for collection blood volume, tissue mass, CD34+, CD90+, CD105+ counts and concentrations. Multiplex immunoassay was used to measure 12 cytokines and growth factors in CB plasma of 74 patients. BPD severity was defined according to NIH consensus definitions. Univariate and multivariate regression models were used to identify perinatal covariates and assess associations between stem cell concentrations, cytokines and BPD outcomes. Results. Of 200 patients enrolled (mean GA=30 ± 2 weeks), 30 developed mild, 24 moderate, and 19 severe BPD. Concentrations of HPSC and MSC, as measured by %CD34+, %CD90+ and %CD105+ of total cells, increased with degree of prematurity. Collection parameters varied with GA, birth weight (BW), gender, prolonged rupture of membranes, mode of delivery, chorioamnionitis, and multiple gestation. Moderate-severe BPD or death was increased with lower GA, BW, Apgar scores, and documented delayed cord clamping. %CD34+ and %CD90+ were increased with BPD and directly correlated with BPD severity. Severe BPD was positively associated with %CD34+ (beta-coefficient=0.9; 95%CI=0.4-1.5; P<0.01) and %CD90+ (beta-coefficient=0.4; 95%CI=0.2-0.6; P<0.001) after adjustment for covariates. CB plasma granulocyte-colony stimulating factor (G-CSF) was inversely associated with %CD90+, and decreased with BPD. Below median G-CSF combined with elevated %CD90+ predicted BPD (positive predictive value=100%). Conclusions. CB and CT collections yielded high concentrations of HPSCs and MSCs in BPD infants, accompanied by low circulating G-CSF. These variations suggest possible mechanisms by which stem cell differentiation and function predict BPD.
30
Bronchopulmonary Dysplasia: Executive Summary of a Workshop
Rosemary D. Higgins, Alan H. Jobe, Marion Koso‐Thomas et al. · The Journal of Pediatrics · 2018 · 977 citations
Gareth R. Willis, Angeles Fernandez‐Gonzalez, Jamie N. Anastas et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 643 citations · Full text
Mesenchymal Stem Cells for Bronchopulmonary Dysplasia: Phase 1 Dose-Escalation Clinical Trial
Yun Sil Chang, So Yoon Ahn, Hye Soo Yoo et al. · The Journal of Pediatrics · 2014 · 464 citations · Full text
Medicine, Pediatrics, Surgery +17